468 related articles for article (PubMed ID: 32807122)
1. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
Chang WH; Lai AG
BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
[TBL] [Abstract][Full Text] [Related]
2. The pan-cancer mutational landscape of the PPAR pathway reveals universal patterns of dysregulated metabolism and interactions with tumor immunity and hypoxia.
Chang WH; Lai AG
Ann N Y Acad Sci; 2019 Jul; 1448(1):65-82. PubMed ID: 31215667
[TBL] [Abstract][Full Text] [Related]
3. An immunoevasive strategy through clinically-relevant pan-cancer genomic and transcriptomic alterations of JAK-STAT signaling components.
Chang WH; Lai AG
Mol Med; 2019 Nov; 25(1):46. PubMed ID: 31684858
[TBL] [Abstract][Full Text] [Related]
4. Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies.
Chang WH; Lai AG
J Transl Med; 2019 Apr; 17(1):132. PubMed ID: 31014368
[TBL] [Abstract][Full Text] [Related]
5. Loss of TP53I11 Enhances the Extracellular Matrix-independent Survival by Promoting Activation of AMPK.
Xiao T; Xu Z; Zhou Y; Zhang H; Geng J; Liang Y; Qiao H; Suo G
IUBMB Life; 2019 Feb; 71(2):183-191. PubMed ID: 30376610
[TBL] [Abstract][Full Text] [Related]
6. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
7. Aberrations in Notch-Hedgehog signalling reveal cancer stem cells harbouring conserved oncogenic properties associated with hypoxia and immunoevasion.
Chang WH; Lai AG
Br J Cancer; 2019 Oct; 121(8):666-678. PubMed ID: 31523055
[TBL] [Abstract][Full Text] [Related]
8. AMPK and Cancer.
Wang Z; Wang N; Liu P; Xie X
Exp Suppl; 2016; 107():203-226. PubMed ID: 27812982
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway.
Sanli T; Steinberg GR; Singh G; Tsakiridis T
Cancer Biol Ther; 2014 Feb; 15(2):156-69. PubMed ID: 24100703
[TBL] [Abstract][Full Text] [Related]
10. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
[TBL] [Abstract][Full Text] [Related]
11. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L
Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363
[TBL] [Abstract][Full Text] [Related]
12. The mixed blessing of AMPK signaling in Cancer treatments.
Sadria M; Seo D; Layton AT
BMC Cancer; 2022 Jan; 22(1):105. PubMed ID: 35078427
[TBL] [Abstract][Full Text] [Related]
13. AMPK and mTOR in cellular energy homeostasis and drug targets.
Inoki K; Kim J; Guan KL
Annu Rev Pharmacol Toxicol; 2012; 52():381-400. PubMed ID: 22017684
[TBL] [Abstract][Full Text] [Related]
14. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
[TBL] [Abstract][Full Text] [Related]
15. [Advances of LKB1-AMPK-mTOR Signaling Pathway in Tumor].
Zhang X; Sun L; Zhong D
Zhongguo Fei Ai Za Zhi; 2011 Aug; 14(8):685-8. PubMed ID: 21859551
[No Abstract] [Full Text] [Related]
16. Effects of AMP-activated protein kinase (AMPK) signaling and essential amino acids on mammalian target of rapamycin (mTOR) signaling and protein synthesis rates in mammary cells.
Appuhamy JA; Nayananjalie WA; England EM; Gerrard DE; Akers RM; Hanigan MD
J Dairy Sci; 2014; 97(1):419-29. PubMed ID: 24183687
[TBL] [Abstract][Full Text] [Related]
17. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
19. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.
Chang WL; Hsu LC; Leu WJ; Chen CS; Guh JH
Oncotarget; 2015 Nov; 6(37):39806-20. PubMed ID: 26447757
[TBL] [Abstract][Full Text] [Related]
20. Differential crosstalk between the AMPK and PI3K/Akt pathways in breast cancer cells of differing genotypes: Leptin inhibits the effectiveness of AMPK activation.
El-Masry OS; Al-Sakkaf K; Brown BL; Dobson PR
Oncol Rep; 2015 Oct; 34(4):1675-80. PubMed ID: 26260992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
